Bionano Announces Presentation of OGM Utility Across Stem Cell Therapy Applications at the International Society for Stem Cell Research (ISSCR) Annual Meeting
June 13, 2023 08:00 ET
|
Bionano Genomics
A sponsored session will feature Dr. Alex Hastie from Bionano, Dr. Suk See De Ravin from National Institute of Health (NIH) and Travis Hardcastle from Synthego presenting on the utility of optical...
Bionano Announces 2023 Winners of its Innovator Research Grant Program
June 12, 2023 08:00 ET
|
Bionano Genomics
Grand prize winner, Dr. Michael Khodadoust at Stanford University in Palo Alto, California, will use the Saphyr® system for research into CTCL (cutaneous t-cell lymphoma)Runner up prize winners are...
Bionano Announces Extensive Lineup of Content at European Conferences Featuring OGM Utility Across a Broad Range of Research Applications
June 08, 2023 08:00 ET
|
Bionano Genomics
SAN DIEGO, June 08, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the company’s robust presence at key European cytogenetic conferences, including the European...
Bionano Announces Commercial Release of New Kits for its Ionic System featuring New Chemistry for Nucleic Acid Extraction from FFPE and Tumor Tissue
June 06, 2023 08:00 ET
|
Bionano Genomics
SAN DIEGO, June 06, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the commercial release of new kits for its Ionic® Purification System featuring new chemistry for...
Bionano to Report First Quarter 2023 Financial Results and Host a Conference Call and Webcast on May 9, 2023
May 02, 2023 08:00 ET
|
Bionano Genomics
SAN DIEGO, May 02, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it will host a conference call and live webcast on Tuesday, May 9, 2023, at 4:30 p.m. Eastern...
Consortium Study Finds Bionano Genomics’ Optical Mapping Essential for Comprehensive Detection of Structural Variants
April 17, 2019 12:00 ET
|
Bionano Genomics
SAN DIEGO, April 17, 2019 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO), a life sciences instrumentation company that develops and markets Saphyr®, a platform for ultra-sensitive and...
The Largest Study Conducted with Bionano’s Platform to Date Reveals Never-Before-Seen Human Genomic Structural Variations
March 05, 2019 08:00 ET
|
Bionano Genomics
SAN DIEGO, March 05, 2019 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO), a life sciences instrumentation company that develops and markets Saphyr®, a platform for ultra-sensitive and...
Bionano Genomics Launches New Capabilities of the Saphyr System to Significantly Increase Its Cost Effectiveness, Speed and Ease of Use for Whole Human Genome Structural Variation Analysis and Digital Cytogenetics
March 01, 2019 08:00 ET
|
Bionano Genomics
SAN DIEGO, March 01, 2019 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO), a life sciences instrumentation company that develops and markets Saphyr, a platform for ultra-sensitive and...
Bionano Genomics’ Saphyr® System Used for Highly Accurate Detection of the Genetic Disorder FSHD as an Alternative to Southern Blot
February 06, 2019 08:00 ET
|
Bionano Genomics
SAN DIEGO, Feb. 06, 2019 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO), a life sciences instrumentation company that develops and markets Saphyr, a platform for ultra-sensitive and...
Global Adoption of Bionano Genomics’ Saphyr® System Accelerating for Clinical Genomics Applications
January 14, 2019 08:00 ET
|
Bionano Genomics
SAN DIEGO, Jan. 14, 2019 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO), a life sciences instrumentation company that develops and markets the Saphyr system, which enables ultra-sensitive...